LWLindsay B. Wichers

Lindsay B. Wichers

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lindsay B. Wichers has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Direction-Projection-Permutation for High-Dimensional Hypothesis Tests

    by Susan Wei, Chihoon Lee, Lindsay Wichers, J. S. Marron

    High-dimensional low sample size (HDLSS) data are becoming increasingly common in statistical applications. When the data can be partitioned into two classes, a basic task is to construct a classifier that can assign objects to the correct class. Binary linear classifiers have been shown to be especially useful in HDLSS settings and preferable to more complicated classifiers because of their ease of interpretability. We propose a computational tool called direction-projection-permutation (DiProPerm), which rigorously assesses whether a binary linear classifier is detecting statistically significant differences between two high-dimensional distributions. The basic idea behind DiProPerm involves working directly with the one-dimensional projections of the data induced by binary linear classifier. Theoretical properties of DiProPerm are studied under the HDLSS asymptotic regime whereby dimension diverges to infinity while sample size remains fixed. We show that certain variations of DiProPerm are consistent and that consistency is a nontrivial property of tests in the HDLSS asymptotic regime. The practical utility of DiProPerm is demonstrated on HDLSS gene expression microarray datasets. Finally, an empirical power study is conducted comparing DiProPerm to several alternative two-sample HDLSS tests to understand the advantages and disadvantages of each method.


  • Open Access

    A method for exposing rodents to resuspended particles using whole-body plethysmography

    by Lindsay B Wichers, Allen D Ledbetter, John K McGee, Robert B Kellogg, William H RowanIII, Julianne P Nolan, Daniel L Costa, William P Watkinson

    Background: Epidemiological studies have reported increased risks of cardiopulmonary-related hospitalization and death in association with exposure to elevated levels of particulate matter (PM) across a wide range of urban areas. In response to these findings, researchers have conducted animal inhalation exposures aimed at reproducing the observed toxicologic effects. However, it is technically difficult to quantitate the actual amount of PM delivered to the lung in such studies, and dose is frequently estimated using default respiration parameters. Consequently, the interpretation of PM-induced effects in rodents exposed via whole-body inhalation is often compromised by the inability to determine deposited dose. To address this problem, we have developed an exposure system that merges the generation of dry, aerosolized particles with whole-body plethysmography (WBP), thus permitting inhalation exposures in the unrestrained rat while simultaneously obtaining data on pulmonary function. Results: This system was validated using an oil combustion-derived particle (HP12) at three nominal concentrations (3, 12, and 13 mg/m3) for four consecutive exposure days (6 hr/day); a single 6-hour exposure to 13 mg/m3 of HP12 was also conducted. These results demonstrated that the system was both reliable and consistent over these exposure protocols, achieving average concentrations that were within 10% of the targeted concentration. In-line filters located on the exhaust outlets of individual WBP chambers showed relative agreement in HP12 mass for each day and were not statistically different when compared to one another (p = 0.16). Temperatures and relative humidities were also similar between chambers during PM and air exposures. Finally, detailed composition analyses of both HP12 filter and bulk samples showed that grinding and aerosolization did not change particle chemistry. Conclusion: The results of this study demonstrate that it is possible to expose rodents to resuspended, dry PM via whole-body inhalation while these animals are maintained in WBP chambers. This new methodology should significantly improve the ability to assess dosimetry under minimally stressful exposure conditions.


  • Open Access

    Particle Deposition in Spontaneously Hypertensive Rats Exposed via Whole-Body Inhalation: Measured and Estimated Dose

    by Lindsay B. Wichers, William H. Rowan, Julianne P. Nolan, Allen D. Ledbetter, John K. McGee, Daniel L. Costa, William P. Watkinson

    A plethora of epidemiological studies have shown that exposure to elevated levels of ambient particulate matter (PM) can lead to adverse health outcomes, including cardiopulmonary-related mortality. Subsequent animal toxicological studies have attempted to mimic these cardiovascular and respiratory responses, in order to better understand underlying mechanisms. However, it is difficult to quantitate the amount of PM deposited in rodent lungs following inhalation exposure, thus making fundamental dose-to-effect assessment and linkages to human responses problematic. To address this need, spontaneously hypertensive rats were exposed to an oil combustion–derived PM (HP12) via inhalation while being maintained in whole-body plethysmograph chambers. Rats were exposed 6 h/day to 13 mg/m3 of HP12 for 1 or 4 days. Immediately following the last exposure, rats were sacrificed and their tracheas and lung lobes harvested and separated for neutron activation analysis. Total lower respiratory tract deposition ranged from 20–60 μg to 89–139 μg for 1- and 4-day exposures, respectively. Deposition data were compared to default and rat-specific estimates provided by the Multiple Path Particle Deposition (MPPD) model, yielding model predictions that were < 33% of the measured dose. This study suggests that HP12 exposure decreased particle clearance, as the mass of HP12 in the lungs following a 4-day protocol was nearly four times that observed after a 1-day exposure. This work should improve the ability of risk assessors to extrapolate rat-to-human exposure concentrations on the basis of lung burdens and, thus, better relate inhaled doses and resultant toxicological effects.